Annual Total Liabilities
$4.11 M
+$2.84 M+225.18%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual total liabilities is currently $4.11 million, with the most recent change of +$2.84 million (+225.18%) on 31 December 2023. During the last 3 years, it has risen by +$3.40 million (+480.92%). BLACU annual total liabilities is now at all-time high.BLACU Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$6.01 M
+$523.00 K+9.53%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly total liabilities is currently $6.01 million, with the most recent change of +$523.00 thousand (+9.53%) on 30 September 2024. Over the past year, it has increased by +$2.84 million (+89.32%). BLACU quarterly total liabilities is now at all-time high.BLACU Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +225.2% | +89.3% |
| 3 y3 years | +480.9% | +750.0% |
| 5 y5 years | - | - |
BLACU Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +480.9% | at high | +750.0% |
| 5 y | 5 years | at high | +1177.5% | at high | +750.0% |
| alltime | all time | at high | +1177.5% | at high | +750.0% |
Bellevue Life Sciences Acquisit Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.01 M(+9.5%) |
| June 2024 | - | $5.49 M(+14.0%) |
| Mar 2024 | - | $4.82 M(+17.2%) |
| Dec 2023 | $4.11 M | $4.11 M(+29.4%) |
| Sept 2023 | - | $3.18 M(+21.6%) |
| June 2023 | - | $2.61 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.47 M(+95.8%) |
| Dec 2022 | $1.26 M(+78.6%) | - |
| Dec 2022 | - | $1.26 M(+6.6%) |
| Sept 2022 | - | $1.19 M(+11.6%) |
| June 2022 | - | $1.06 M(+50.2%) |
| Dec 2021 | $707.20 K(+119.9%) | $707.20 K |
| Dec 2020 | $321.60 K | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual total liabilities?
- What is the all time high annual total liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual total liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly total liabilities year-on-year change?
What is Bellevue Life Sciences Acquisit annual total liabilities?
The current annual total liabilities of BLACU is $4.11 M
What is the all time high annual total liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual total liabilities is $4.11 M
What is Bellevue Life Sciences Acquisit annual total liabilities year-on-year change?
Over the past year, BLACU annual total liabilities has changed by +$2.84 M (+225.18%)
What is Bellevue Life Sciences Acquisit quarterly total liabilities?
The current quarterly total liabilities of BLACU is $6.01 M
What is the all time high quarterly total liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly total liabilities is $6.01 M
What is Bellevue Life Sciences Acquisit quarterly total liabilities year-on-year change?
Over the past year, BLACU quarterly total liabilities has changed by +$2.84 M (+89.32%)